"Postpartum depression" from_date:2012

Antenatal screening timeline and cutoff scores of the Edinburgh Postnatal Depression Scale for predicting postpartum depressive symptoms in healthy women: a prospective cohort study. It is worthwhile to identify women at risk of developing postpartum depression during pregnancy. This study aimed to determine the optimal time and cutoff score for antenatal screening for prediction of postpartum depressive symptoms (PDS) using the Edinburgh Postnatal Depression Scale (EPDS) and to identify risk factors for PDS. The target population was healthy pregnant women receiving antenatal care at a university hospital in Tokyo, Japan. During the first, second, and third trimesters, 3-4 days postpartum, and one month postpartum, they were asked to take the Japanese version of the EPDS questionnaire

Postpartum depressive symptoms of Brazilian women during the COVID-19 pandemic measured by the Edinburgh Postnatal Depression Scale. The COVID-19 pandemic gave rise to concerns about its potential impact on the mental health of pregnant and postpartum women as the general postpartum depression rates increased. Three postpartum questionnaires (Edinburgh Postnatal Depression Scale - EPDS; Anxiety and Depression Scale - HAD; and a demographic questionnaire about isolation and information acquisition) were used to evaluate the mental health of women with and without COVID-19 and determine the factors associated with depressive symptoms (EPDS ≥ 12). Data from 184 participants with a mean of 56 postpartum days were analyzed. The rate of symptoms compatible with postpartum depression (PPD) was 38.8

Postnatal depression Skip to main contentSkip to searchLog inEnglish#{autosuggest.search}#{autosuggest.search}Postnatal depression MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:17 Dec 2023Last updated:12 Jan 2024IMPORTANT UPDATESSummaryPostnatal depression may present with symptoms of depressed mood, anhedonia, weight changes, sleep disturbance, psychomotor problems , low energy, excessive guilt, loss of confidence or self-esteem, poor concentration, or suicidal ideation.Recognition and effective treatment is vital; untreated postnatal depression causes substantial impairment for the woman, and may also result in impaired behavioural, emotional, and cognitive outcomes for the baby.Exclude postnatal psychosis and bipolar disorder in all patients.Treatment

Culturally-adapted therapy improved postnatal depression in British South Asian women Culturally-adapted therapy improved postnatal depressionCulturally-adapted therapy improved postnatal depressionSkip to content * Accessibility options: * * Search articles Evidence * About us * Browse content * Brain and Nerves * Birth Conditions * Blood * Cancer * Dementia * Detection, Screening and Diagnosis * Become a reviewer * Newsletter sign up * Contact us * Homepage * > * Alert * > * Culturally-adapted therapy improved postnatal depression in British South Asian women Culturally-adapted therapy improved postnatal depression in British South Asian womenMental Health 13.03.25 doi: 10.3310/nihrevidence_66043 View commentaries and related content This is a plain English summary of an original research

Effectiveness of interpersonal psychotherapy in comparison to other psychological and pharmacological interventions for reducing depressive symptoms in women diagnosed with postpartum depression in low- and middle-income countries: A systematic review Skip to contentHomeOur workGet involvedUpdatesAboutSearchEffectiveness of interpersonal psychotherapy in comparison to other psychological and pharmacological interventions for reducing depressive symptoms in women diagnosed with postpartum depression in low- and middle-income countries: A systematic reviewApr 21, 2024 — by AdminPostpartum depression (PPD) Depression is a common mental health issue that many women experience during their childbearing years. It can manifest as persistent feelings of sadness and emptiness that last for more than 2 weeks

.Wickberg B, Hwang CP. The Edinburgh Postnatal Depression Scale: validation on a Swedish community sample. Acta Psychiatr Scand. 1996;94(3):181-4. Available from: https://doi.org/10.1111/j.1600-0447.1996.tb09845.x.Falah-Hassani K, Shiri R, Vigod S, Dennis CL. Prevalence of postpartum depression among immigrant women: A systematic review and meta-analysis. J Psychiatr Res. 2015;70:67-82. Available from : a qualitative systematic review. Birth. 2006;33(4):323-31. Available from: https://doi.org/10.1111/j.1523-536X.2006.00130.x.Stewart DE, Vigod S. Postpartum Depression. N Engl J Med. 2016;375(22):2177-86. Available from: https://doi.org/10.1056/NEJMcp1607649.Holden JM, Sagovsky R, Cox JL. Counselling in a general practice setting: controlled study of health visitor intervention in treatment of postnatal

Zuranolone (Zurzuvae) - postpartum depression Skip to main contentSkip to FDA SearchSkip to footer links An official website of the United States government Here's how you know U.S. Food and Drug Administration  Search   MenuSearch FDASubmit search Home Drugs Drug Approvals and Databases Drugs@FDADrug Approval Package: ZURZUVAEShareTweetLinkedinEmailPrintCompany: Sage Therapeutics

Antenatal and postnatal depression CKS is only available in the UK | NICE CKS is only available in the UKThe NICE Clinical Knowledge Summaries (CKS) site is only available to users in the UK, Crown Dependencies and British Overseas Territories.CKS content is produced by Clarity Informatics Limited. It is available to users outside the UK via subscription from the Prodigy website.If you believe

Zuranolone for the Treatment of Postpartum Depression Skip to main contentMenuClinical GuidancePractice AdvisoryZuranolone for the Treatment of Postpartum DepressionZuranolone for the Treatment of Postpartum DepressionPractice AdvisoryPAAugust 2023Jump toSearch pageResourcesShareTwitterFacebookLinkedInEmailPrintBy reading this page you agree to ACOG's Terms and Conditions.  Read termsThis medication indicated to treat postpartum depression in adults 2.Perinatal mental health conditions via suicide and overdose/poisoning are the leading cause of overall and preventable maternal mortality 34, and thus understanding, discussing, and recommending treatment, including pharmacotherapy when indicated and needed, is within the scope of the obstetrician–gynecologist’s practice 1. Perinatal

Postnatal depression Postnatal depression - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * About us * Help * Subscribe * Access through your institution * Log inBMJ Best Practice * Help * Getting started * FAQs * Contact us * Recent updates * Specialties * Calculators * Patient leaflets * Videos * Evidence * Drugs * Recent updates depression causes substantial impairment for the woman, and may also result in impaired behavioural, emotional, and cognitive outcomes for the baby.Women with postnatal depression may present with a history of depressed mood, anhedonia, weight changes, sleep disturbance, psychomotor problems, low energy, excessive guilt, loss of confidence or self-esteem, poor concentration, or suicidal ideation.Exclude

Efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women (ROSHNI-2): a multicentre, randomised controlled trial. Postnatal depression necessitates timely and effective interventions to mitigate adverse maternal and child outcomes in the short term and over the life course. British south Asian women with depression are often underserved and undertreated due to stigma, language barriers, and cultural barriers. This trial aimed to test the clinical efficacy of a culturally adapted, group cognitive behavioural therapy (CBT)-based intervention, the Positive Health Programme (PHP), delivered by non-specialist health workers for postnatal depression in British south Asian women. This study was a randomised controlled

Intraoperative Esketamine and Postpartum Depression Among Women With Cesarean Delivery: A Randomized Clinical Trial Esketamine has been found to reduce the incidence of postpartum depression (PPD) in randomized clinical trials. However, current evidence from randomized clinical trials does not reflect esketamine's efficacy in clinical settings. To assess the clinical efficacy of intraoperative at 6 weeks post partum. PPD was assessed using the Edinburgh Postnatal Depression Scale. A total of 308 pregnant women were randomly assigned to 1 of 2 groups: esketamine (n = 154; mean [SD] patient age, 31.57 [4.26] years) and control (n = 154; mean [SD] patient age, 32.53 [7.74] years). Incidence of PPD was significantly lower in the esketamine group compared with the control group at 6 weeks post

and management. The impact of an antenatal hospitalization during pregnancy on postnatal depression remains understudied. To evaluate whether hospital admission during pregnancy was associated with postpartum depressive symptoms in individuals who were enrolled in a collaborative care model and to evaluate whether enrollment in the collaborative care model during pregnancy mitigated this association Association Between Antepartum Admission and Postpartum Depressive Symptoms: Short Title: Antepartum Hospital Admission and Postpartum Depressive Symptoms. Postpartum depression affects 14% of pregnant individuals and is a leading cause of preventable maternal mortality. Complications of pregnancy, such as preterm labor or pre-eclampsia, may require hospitalization for close monitoring

Practical Resources for Effective Postpartum Parenting (PREPP): a randomized controlled trial of a novel parent-infant dyadic intervention to reduce symptoms of postpartum depression: RCT of the PREPP intervention for postpartum depression. There is little known about the effectiveness of psychological interventions to prevent postpartum depression that focus on the birthing parent and infant dyad. Risk factors for PPD include depression during pregnancy, low parenting self-efficacy, and disrupted parental nocturnal sleep. The brief Practical Resources for Effective Postpartum Parenting (PREPP) intervention is designed for pregnant individuals at-risk for postpartum depression, providing them with 1) caregiving strategies aimed at reducing infant fuss and cry behavior and increasing

Factor structure and longitudinal measurement invariance of Edinburgh Postnatal Depression Scale during the whole perinatal period: a multicenter cohort study in China. Perinatal depression is common worldwide, which can cause many adverse effects on the physical and mental health of the mother and baby, as well as the whole family. The Edinburgh Postnatal Depression Scale (EPDS) is an efficient

Comparative assessment of Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale for screening antenatal depression among Chinese pregnant women. The Patient Health Questionnaire-9 (PHQ-9) and Edinburgh Postnatal Depression Scale (EPDS) are commonly used for assessing antenatal depression in China. However, clear guidelines for their application are lacking in China, leading

Does the Edinburgh Postnatal Depression Scale (EPDS) identify antenatal depression and antenatal anxiety disorders? A validation study in Singapore. Research on the usage of the Edinburgh Postnatal Depression Scale (EPDS) to detect common antenatal mental disorders in pregnant women attending outpatient clinics in Singapore is limited. This study aimed to investigate the psychometric properties

Cost-effectiveness of a group psychological intervention for postnatal depression in British south Asian women: an economic evaluation from the ROSHNI-2 trial. Minority ethnic groups often face ethnocultural barriers in accessing mental health treatments. The ROSHNI-2 trial compared culturally adapted cognitive behavioural therapy (Positive Health Programme [PHP]) with treatment as usual for postnatal depression in British south Asian women. We aimed to assess the cost-effectiveness of the PHP intervention. The ROSHNI-2 trial was a multicentre, two-arm, assessor-blinded, randomised controlled trial; we conducted an economic evaluation over a 12-month period to assess the cost-effectiveness of PHP plus treatment as usual versus treatment as usual alone from the perspective of the English

Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression: A Randomized Clinical Trial Postpartum depression (PPD) is emerging as a major public health problem worldwide. Although the particular period and context in which PPD occurs provides an opportunity for preventive interventions, there is still a lack of pharmacologic prevention strategies for PPD. To assess the efficacy and safety of dexmedetomidine for prevention of PPD among women with prenatal depression undergoing cesarean delivery. This randomized clinical trial enrolled 338 women who screened positive for prenatal depression at 2 hospitals in Hunan, China from March 28, 2022, to April 16, 2023. Women with an Edinburgh Postnatal Depression Scale score of more than 9 who were 18 years of age or older

Association between breastfeeding cessation among under six-month-old infants and postpartum depressive symptoms in Nevada. Postpartum depression affects 13% of women after childbirth in the United States. Mothers who experience depression are less likely to breastfeed than those who do not experience depression. On the other hand, breastfeeding may have a positive effect on maternal mental health. We aimed to analyze whether breastfeeding cessation is associated with postpartum depression symptoms among mothers of infants under six months old in Clark County, Nevada. A cross-sectional study was conducted in 2021 using a purposive sample of 305 mother-infant dyads. Postpartum depression symptoms were assessed using the Patient Health Questionnaire-2 (PHQ-2), and the breastfeeding